Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) Institutional Ownership

CUSIP: G0864B103

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Ordinary Shares with no par value
Symbol
BMGL on Nasdaq
Shares outstanding
18,772,286
Price per share
$0.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
143,220
Total reported value
$70,178
% of total 13F portfolios
0%
Share change
-146,252
Value change
-$322,542
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP G0864B103?
CUSIP G0864B103 identifies BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rainforest Capital VCC 54% $44,768,148 10,174,579 Rainforest Capital VCC 21 Feb 2025

As of 31 Dec 2025, 8 institutional investors reported holding 143,220 shares of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL). This represents 0.76% of the company’s total 18,772,286 outstanding shares.

Institutional Holders of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 143,220 $70,178 -$322,542 $0.49 8
2025 Q3 289,472 $524,583 +$302,834 $1.82 9
2025 Q2 124,340 $221,398 +$196,613 $1.78 6